Apoptosis regulator Bcl-2

Description:

Description
  • Accession: P10415
  • Swissprot: BCL2_HUMAN
  • Organism: Homo sapiens
  • Gene: BCL2
  • Target class: Cytosolic other

Drug Relations:

venetoclax
Venetoclax is a selective and orally bioavailable small-molecule inhibitor of BCL-2, an anti-apoptotic protein. Overexpression of BCL-2 has been demonstrated in CLL cells where it mediates tumor cell survival and has been associated with resistance to chemotherapeutics. Venetoclax helps restore the process of apoptosis by binding directly to the BCL-2 protein, displacing pro-apoptotic proteins like BIM, triggering mitochondrial outer membrane permeabilization and the activation of caspases. In nonclinical studies, venetoclax has demonstrated cytotoxic activity in tumor cells that overexpress BCL-2. Bioactivity details MOA
chlorcyclizine
Bioactivity details MOA
gossypol
A dimeric sesquiterpene found in cottonseed (GOSSYPIUM). The (-) isomer is active as a male contraceptive (CONTRACEPTIVE AGENTS, MALE) whereas toxic symptoms are associated with the (+) isomer. Bioactivity details MOA